Nanotechnology Now

Our NanoNews Digest Sponsors





Heifer International

Wikipedia Affiliate Button


android tablet pc

Home > Press > NanoViricides Appoints Leading Hepatitis C Expert to Advisory Board

Abstract:
Dr. Howard A. Fields joins the Scientific Advisory Board after retiring from the CDC as Team Leader of the Assay Development and Cell Culture Team within the Division of Viral Hepatitis

NanoViricides Appoints Leading Hepatitis C Expert to Advisory Board

WEST HAVEN, CT | Posted on February 4th, 2008

NanoViricides, Inc. (OTC BB: NNVC.OB) (the "Company"), announced today that Dr. Howard A. Fields has joined the Scientific Advisory Board (SAB) of NanoViricides, Inc. "We are taking steps to accelerate our Hepatitis C antiviral nanoviricides program," said Eugene Seymour, MD, MPH, CEO of the Company, adding "We are delighted to have Dr Fields, an internationally renowned authority, join our SAB to guide this program."

"I have been very excited by the nanoviricides technology," said Dr. Fields about his joining the Company's SAB, adding, "I believe it represents the next step beyond immunotherapeutics, and has great potential."

Dr. Fields is a distinguished international expert in Viral Hepatitis. During his thirty-two year career at the CDC, he was the Team Leader of Assay Development and Cell Culture Team within the Division of Viral Hepatitis at the Centers for Disease Control and Prevention (CDC), where he led the research on all hepatitis viruses including Hepatitis C virus, and Hepatitis B virus from 2002 until his recent retirement. Prior to that, he was Chief, Molecular and Immunodiagnostic Section (MIDS), Hepatitis Branch, Division of Viral and Rickettsial Diseases. From 1990 to 1994, he was given the responsibility for the conduct of the WHO Collaborating Centre for Reference and Research on Viral Hepatitis at CDC particularly regarding technology transfer issues.

Dr Fields holds six US and international patents, with additional six patent applications pending. He has more than 150 research publications. Dr. Fields holds a PhD in Microbiology from the University of New Hampshire.

####

About NanoViricides, Inc.
NanoViricides, Inc. (www.nanoviricides.com) is a development stage company that is creating special purpose nanomaterials for viral therapy. The Company's novel nanoviricide™ class of drug candidates are designed to specifically attack enveloped virus particles and to dismantle them. The Company is developing drugs against a number of viral diseases including H5N1 bird flu, seasonal influenza, HIV, hepatitis C, rabies, and dengue fever, among others.

This press release contains forward-looking statements that reflect the Company's current expectation regarding future events. Forward-looking statements involve risks and uncertainties. Actual events could differ materially and substantially from those projected herein and depend on a number of factors. Certain statements in this release, and other written or oral statements made by NanoViricides, Inc. are “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward looking statements are subject to known and unknown risks, uncertainties and other factors that may cause actual results, performance, or achievements of the company to be different from those expressed or implied including the success of the Company's research and development efforts, the availability of adequate financing, the successful and timely completion of clinical studies and the uncertainties related to the regulatory process, described in the “Management’s Discussion and Analysis” section of the Company’s Form 10-KSB and other reports and filings with the Securities and Exchange Commission.

For more information, please click here

Contacts:
NanoViricides, Inc.
Amanda Schuon
310-550-7200

Copyright © Business Wire 2008

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

The Hiden EQP Plasma Diagnostic with on-board MCA July 22nd, 2014

Bruker Awarded Fourth PeakForce Tapping Patent: AFM Mode Uniquely Combines Highest Resolution Imaging and Material Property Mapping July 22nd, 2014

NIST shows ultrasonically propelled nanorods spin dizzyingly fast July 22nd, 2014

Penn Study: Understanding Graphene’s Electrical Properties on an Atomic Level July 22nd, 2014

Nanomedicine

NIST shows ultrasonically propelled nanorods spin dizzyingly fast July 22nd, 2014

SentiMag® Now Available in Australia and New Zealand July 21st, 2014

More than glitter: Scientists explain how gold nanoparticles easily penetrate cells, making them useful for delivering drugs July 21st, 2014

Iranian Scientists Use Nanosensors to Achieve Best Limit for Early Cancer Diagnosis July 19th, 2014

Announcements

Nanometrics Announces Upcoming Investor Events July 22nd, 2014

Bruker Awarded Fourth PeakForce Tapping Patent: AFM Mode Uniquely Combines Highest Resolution Imaging and Material Property Mapping July 22nd, 2014

NIST shows ultrasonically propelled nanorods spin dizzyingly fast July 22nd, 2014

Penn Study: Understanding Graphene’s Electrical Properties on an Atomic Level July 22nd, 2014

Appointments/Promotions/New hires/Resignations/Deaths

NSS Pays Tribute to Space Pioneer Frederick I. Ordway III July 7th, 2014

Harris & Harris Group Announces Changes to Its Legal Department June 9th, 2014

SEMATECH Appoints Satyavolu Papa Rao to Lead Process Technology May 13th, 2014

Agilent Technologies Names Jay Alexander as Chief Technology Officer of Keysight Technologies May 7th, 2014

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More














ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







© Copyright 1999-2014 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE